According to our latest research, the global rare disease genetic testing market size reached USD 2.1 billion in 2024. The market is poised for robust growth, expected to achieve a CAGR of 12.5% from 2025 to 2033. By the end of 2033, the market is projected to attain a value of USD 6.1 billion. This impressive expansion is primarily driven by the growing prevalence of rare diseases, increased awareness about genetic disorders, and significant advancements in genomic technologies. The integration of advanced diagnostic platforms and the growing adoption of personalized medicine are further propelling this market forward, making it a critical segment within the broader healthcare landscape.
https://growthmarketreports.co....m/report/rare-diseas
